RMD
ResMed Inc. NYSE Listed Jun 2, 1995$206.96
Mkt Cap $30.0B
52w Low $198.64
8.7% of range
52w High $293.81
50d MA $230.02
200d MA $254.99
P/E (TTM)
21.5x
EV/EBITDA
19.6x
P/B
5.0x
Debt/Equity
0.1x
ROE
22.9%
P/FCF
22.8x
RSI (14)
—
ATR (14)
—
Beta
0.93
50d MA
$230.02
200d MA
$254.99
Avg Volume
1.1M
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
9001 Spectrum Center Boulevard · San Diego, CA 92123 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 2.79 | 2.86 | +2.5% | 213.81 | -3.7% | -4.1% | +2.2% | -0.7% | +0.8% | -1.3% | — |
| Jan 29, 2026 | AMC | 2.74 | 2.81 | +2.6% | 257.61 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% | — |
| Oct 30, 2025 | AMC | 2.51 | 2.55 | +1.6% | 252.26 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% | — |
| Jul 31, 2025 | AMC | 2.55 | 2.55 | +0.0% | 271.94 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% | — |
| Apr 23, 2025 | AMC | 2.38 | 2.37 | -0.4% | 214.36 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% | — |
| Jan 30, 2025 | AMC | 2.32 | 2.43 | +4.7% | 257.65 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% | — |
| Oct 24, 2024 | AMC | 2.04 | 2.20 | +7.8% | 239.05 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% | — |
| Aug 1, 2024 | AMC | 2.07 | 2.08 | +0.5% | 214.56 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% | — |
| Apr 25, 2024 | AMC | 1.91 | 2.13 | +11.5% | 183.42 | +10.7% | +18.9% | -0.4% | -1.5% | +0.5% | +1.5% | — |
| Jan 24, 2024 | AMC | 1.81 | 1.88 | +3.9% | 171.78 | +10.4% | +8.5% | +2.0% | +0.6% | +0.1% | -0.6% | — |
| Oct 26, 2023 | AMC | 1.62 | 1.64 | +1.2% | 138.73 | +4.4% | -2.9% | +2.1% | +2.7% | +4.2% | +2.0% | — |
| Aug 3, 2023 | AMC | 1.69 | 1.60 | -5.3% | 219.95 | -9.8% | -18.5% | +4.1% | -4.0% | -1.3% | +0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $213.81 | $206.00 | -3.7% | -4.1% | +2.2% | -0.7% | +0.8% | -1.3% |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $213.81 | $206.00 | -3.7% | -4.1% | +2.2% | -0.7% | +0.8% | -1.3% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $219.85 | $219.13 | -0.3% | +1.0% | -2.2% | -2.4% | +0.9% | -4.1% |
| Apr 9 | Citigroup | Maintains | Buy → Buy | — | $230.70 | $227.99 | -1.2% | -1.2% | +0.4% | +0.6% | +0.2% | -0.8% |
| Feb 2 | Citigroup | Maintains | Buy → Buy | — | $258.31 | $257.18 | -0.4% | -1.4% | -1.3% | +4.6% | +1.5% | +1.7% |
| Jan 30 | RBC Capital | Maintains | Outperform → Outperform | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Jan 30 | Stifel | Maintains | Hold → Hold | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Jan 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Jan 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Dec 18 | Stifel | Maintains | Hold → Hold | — | $245.94 | $246.10 | +0.1% | -1.4% | +1.0% | +0.7% | -0.8% | -0.1% |
| Dec 16 | Baird | Downgrade | Outperform → Neutral | — | $253.07 | $248.01 | -2.0% | -2.3% | -0.6% | -1.4% | +1.0% | +0.7% |
| Nov 3 | Baird | Maintains | Outperform → Outperform | — | $246.88 | $247.54 | +0.3% | +0.8% | -1.0% | -0.5% | +1.8% | +0.7% |
| Oct 31 | RBC Capital | Maintains | Outperform → Outperform | — | $252.26 | $254.51 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% |
| Oct 31 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $252.26 | $254.51 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% |
| Oct 31 | Mizuho | Maintains | Outperform → Outperform | — | $252.26 | $254.51 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% |
| Oct 21 | Morgan Stanley | Maintains | Overweight → Overweight | — | $271.41 | $268.02 | -1.2% | -1.2% | -0.6% | -0.5% | -2.2% | -0.1% |
| Aug 1 | Mizuho | Maintains | Outperform → Outperform | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | UBS | Maintains | Buy → Buy | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | RBC Capital | Maintains | Outperform → Outperform | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | Stifel | Maintains | Hold → Hold | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Jul 16 | Mizuho | Maintains | Outperform → Outperform | — | $252.01 | $253.77 | +0.7% | +0.9% | +0.9% | +0.6% | +1.2% | +2.4% |
| Jul 16 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $252.01 | $253.77 | +0.7% | +0.9% | +0.9% | +0.6% | +1.2% | +2.4% |
| Apr 24 | Piper Sandler | Maintains | Neutral → Neutral | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | UBS | Maintains | Buy → Buy | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | JP Morgan | Maintains | Overweight → Overweight | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 21 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $212.91 | $211.62 | -0.6% | -1.0% | +1.5% | +0.1% | +10.1% | -0.1% |
| Mar 5 | Citigroup | Upgrade | Neutral → Buy | — | $231.48 | $227.71 | -1.6% | -3.3% | +0.5% | +3.3% | +1.8% | -4.6% |
| Mar 5 | Stifel | Maintains | Hold → Hold | — | $231.48 | $227.71 | -1.6% | -3.3% | +0.5% | +3.3% | +1.8% | -4.6% |
| Jan 31 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Jan 31 | Piper Sandler | Maintains | Neutral → Neutral | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Jan 31 | JP Morgan | Maintains | Overweight → Overweight | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Jan 31 | Needham | Maintains | Hold → Hold | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Oct 25 | Baird | Maintains | Outperform → Outperform | — | $239.05 | $260.00 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% |
| Oct 25 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $239.05 | $260.00 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% |
| Oct 25 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $239.05 | $260.00 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% |
| Oct 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $244.12 | $245.37 | +0.5% | -2.2% | +0.0% | -0.2% | -1.9% | -0.7% |
| Sep 26 | BofA Securities | Maintains | Buy → Buy | — | $240.75 | $245.83 | +2.1% | +0.8% | -1.5% | +2.1% | -2.2% | +0.0% |
| Sep 18 | Wolfe Research | Downgrade | Peer Perform → Underperform | — | $250.88 | $233.63 | -6.9% | -5.1% | +2.1% | +0.8% | +0.5% | +0.4% |
| Sep 4 | Needham | Downgrade | Buy → Hold | — | $244.90 | $239.90 | -2.0% | -0.1% | +0.0% | +0.0% | +1.9% | +1.3% |
| Aug 2 | Needham | Maintains | Buy → Buy | — | $214.56 | $210.00 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% |
| Aug 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $214.56 | $210.00 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% |
| Aug 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $214.56 | $210.00 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% |
| Jul 23 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $207.28 | $207.74 | +0.2% | +1.1% | -1.6% | +1.0% | -5.4% | +5.8% |
| Jun 25 | Oppenheimer | Downgrade | Outperform → Perform | — | $182.20 | $185.07 | +1.6% | +0.9% | +1.5% | +2.7% | -0.1% | -2.3% |
| Jun 24 | Citigroup | Downgrade | Buy → Neutral | — | $205.83 | $189.95 | -7.7% | -11.5% | +0.9% | +1.5% | +2.7% | -0.1% |
| Jun 24 | Needham | Maintains | Buy → Buy | — | $205.83 | $189.95 | -7.7% | -11.5% | +0.9% | +1.5% | +2.7% | -0.1% |
No insider trades available.
Data updated apr 26, 2026 11:08pm
· Source: massive.com